VGIAX yields 11.29% · JNJ yields 2.13%● Live data
📍 VGIAX pulled ahead of the other in Year 1
Combined, VGIAX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VGIAX + JNJ for your $10,000?
This fund seeks to outperform the Standard & Poor’s 500 Index. The fund’s quantitative and fundamental investment approaches result in risk and sector profiles that are similar to those of its benchmark index. The fund has a total return goal, meaning that it seeks both capital appreciation and dividend income. The key risk for the fund is the volatility that comes with its full exposure to the stock market. The fund provides broad exposure to a diverse group of large U.S. companies and may be considered a primary equity holding in a portfolio.
Full VGIAX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.